Adequate sleep (about seven to eight hours for adults) is crucial to your health, alertness and more. Obstructive sleep apnea ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...

Obstructive sleep apnea is associated with an increased risk of coronary heart disease, arrhythmias, and heart failure. Read ...

Matt Fuchs lives in Maryland and writes about health, science, and technology. Matt Fuchs lives in Maryland and writes about health, science, and technology. As a young physician in Sydney, Australia ...

The good news about obstructive sleep apnea (OSA) is that it’s a very treatable condition, for the most part. Continuous positive airway pressure (CPAP) therapy is not only highly effective at helping ...

Obstructive sleep apnea (OSA) is typically measured on a scale called the apnea-hypopnea index (AHI), which determines how many times you stop breathing (apnea) and how often your breathing is ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

Struggling to fall asleep and stopping breathing at night may be a far riskier combo than previously thought. In a study of ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

The buzz is growing around sleep apnea right now, thanks to a potential “sleep apnea pill” and other promising new treatments on the horizon. Yet experts say the next real breakthrough won’t come from ...